$1B for new COVID vaccines, $300M for new antibody to protect vulnerable
The money will be split by small biotech companies that might struggle to pay for clinical trials comparing new vaccines against those now available.
Source: usatoday.com
Stay updated with breaking news from Development Authority Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The money will be split by small biotech companies that might struggle to pay for clinical trials comparing new vaccines against those now available.
The U.S. Department of Health and Human Services has entered into its first ever venture capital partnership, a public-private agreement that's ultimately meant to combat future pandemics and other types of health emergencies.